New treatments for opioid addiction
Novel Therapeutics for Treating Opioid Use Disorder
['FUNDING_FELLOWSHIP'] · VIRGINIA COMMONWEALTH UNIVERSITY · NIH-11071519
This study is looking at a new way to help people with Opioid Use Disorder by testing a drug called Nor-Levo-α-acetylmethadol (nor-LAAM) to see if it can provide better and safer treatment options than what’s currently available.
Quick facts
| Phase | ['FUNDING_FELLOWSHIP'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VIRGINIA COMMONWEALTH UNIVERSITY (nih funded) |
| Locations | 1 site (RICHMOND, UNITED STATES) |
| Trial ID | NIH-11071519 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative therapies for Opioid Use Disorder (OUD), a serious condition affecting many individuals. The project aims to explore the potential of Nor-Levo-α-acetylmethadol (nor-LAAM), a metabolite of an existing drug, to improve treatment outcomes. By optimizing drug delivery methods, the research seeks to enhance the effectiveness of therapies while minimizing side effects, such as cardiovascular risks associated with current treatments. Patients may benefit from a more effective and safer alternative to existing OUD medications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Opioid Use Disorder who are seeking alternative treatment options.
Not a fit: Patients who are not struggling with opioid addiction or those who have contraindications to the study medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with more effective and safer treatment options for opioid addiction.
How similar studies have performed: Previous research has shown promise in using similar approaches to improve treatment for opioid addiction, indicating potential for success in this area.
Where this research is happening
RICHMOND, UNITED STATES
- VIRGINIA COMMONWEALTH UNIVERSITY — RICHMOND, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: INGABIRE, DIANE — VIRGINIA COMMONWEALTH UNIVERSITY
- Study coordinator: INGABIRE, DIANE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.